The biomanufacturing industry is currently undergoing a revolution in how it produces biopharmaceutical products. The driving force behind this paradigm shift is known as Bioprocess 4.0 or Industry 4.0. The approach focuses on how to apply data, predictive modeling, analytics, machine learning, artificial intelligence, automation, and technology for the digital transformation of biologics manufacturing. It’s all about using data from raw materials and bioproduction operations to optimize the process. The overall goals are to improve efficiency, lower costs, and help customers get their products to market faster.

In this GEN podcast, we’ll hear from experts at MilliporeSigma on how the company is applying the principles of Bioprocess 4.0 to its own biomanufacturing strategy and operations.


Jim Neville
Director Technology Management – Amercias

John Cyganowski
Director Manufacturing Sciences & Technologies – Americas

The post Trends in Bioprocess 4.0 and their Impact on Biomanufacturing appeared first on GEN – Genetic Engineering and Biotechnology News.